Australian Clinical Labs (ASX:ACL) Long-Term Debt : A$225.3 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Australian Clinical Labs Long-Term Debt?

Australian Clinical Labs's Long-Term Debt for the quarter that ended in Dec. 2023 was A$225.3 Mil.

Australian Clinical Labs's quarterly Long-Term Debt declined from Dec. 2022 (A$225.8 Mil) to Jun. 2023 (A$65.7 Mil) but then increased from Jun. 2023 (A$65.7 Mil) to Dec. 2023 (A$225.3 Mil).

Australian Clinical Labs's annual Long-Term Debt declined from Jun. 2021 (A$99.5 Mil) to Jun. 2022 (A$0.0 Mil) but then increased from Jun. 2022 (A$0.0 Mil) to Jun. 2023 (A$65.7 Mil).

Australian Clinical Labs Long-Term Debt Historical Data

The historical data trend for Australian Clinical Labs's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Australian Clinical Labs Long-Term Debt Chart

Australian Clinical Labs Annual Data

Trend

Dec20

Jun21

Jun22

Jun23

Long-Term Debt

103.60

99.51

65.70

Australian Clinical Labs Semi-Annual Data
	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Long-Term Debt	Get a 7-Day Free Trial			198.28	-	225.78	65.70	225.26

Australian Clinical Labs (ASX:ACL) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Australian Clinical Labs Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Australian Clinical Labs's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Australian Clinical Labs (ASX:ACL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Australian Clinical Labs Ltd (ASX:ACL) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

1868-1892 Dandenong Road, Clayton, VIC, AUS, 3168

Website

https://www.clinicallabs.com.au

Australian Clinical Labs, or ACL, is Australia's third-largest private pathology provider. ACL earns almost its entire group revenue from pathology services in Australia, which are mostly earned via the publicly funded health Medicare system. ACL is well-established in the states of Western Australia, South Australia, Victoria and the Northern Territory.

Australian Clinical Labs (ASX:ACL) Headlines

No Headlines